SCHEMBL31703869

SCHEMBL31703869

Cc1sc(-c2ccc(F)c(Cl)c2)nc1C(=O)NCc1cccc[n+]1[O-]

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ DRD4 P21917 1/20 0.38
▸ MGLL Q99685 1/20 0.37
▸ MDM2 Q00987 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ P2RX7 Q99572 1/20 0.35
▸ CTSA P10619 1/20 0.35
▸ MAP3K8 P41279 2/20 0.35
▸ EGFR P00533 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPKAPK2 P49137 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ F2 P00734 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ TRPA1 O75762 1/20 0.34
▸ SLC40A1 Q9NP59 1/20 0.34
▸ EIF4E P06730 1/20 0.34
▸ APEX1 P27695 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31703870 1.00 TP53 (0.39) TP53MAPTDRD4MGLLMDM2
SCHEMBL31704088 0.83 PPARA (0.46) TP53MAPTNPC1
SCHEMBL31703731 0.81 IRAK4 (0.45) MAPTP2RX7CYP3A4EIF4E
SCHEMBL31703902 0.78 APOBEC3A (0.36) MAPTSLC40A1
SCHEMBL26617196 0.76 DRD4 (0.48) TP53DRD4NPC1
SCHEMBL18003622 0.75 KDM4E (0.47) MAPTNPC1ABL1
SCHEMBL31703765 0.74 PPARA (0.42) TP53MAPTNPC1
SCHEMBL6495754 0.74 MDM2 (0.47) TP53MAPTMDM2NPC1ABL1
SCHEMBL31703745 0.74 IRAK4 (0.47) MAPTNPC1P2RX7CYP3A4
SCHEMBL31703848 0.74 IRAK4 (0.45) MAPTCYP3A4EIF4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215450-A1 THIAZOLE COMPOUNDS AS SODIUM CHANNEL BLOCKERS SK BIOPHARMACEUTICALS CO., LTD. (KR) 2025-10-16 — — WO claimed
WO-2025215450-A1 THIAZOLE COMPOUNDS AS SODIUM CHANNEL BLOCKERS SK BIOPHARMACEUTICALS CO., LTD. (KR) 2025-10-16 — — WO disclosed
Send feedback